A Pharmacodynamic and Pharmacokinetic Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Acute Pancreatitis
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2019
At a glance
- Drugs CM 4620 (Primary)
- Indications Pancreatitis
- Focus Therapeutic Use
- Sponsors CalciMedica
- 29 Jan 2019 Planned End Date changed from 1 Apr 2019 to 1 Jun 2019.
- 29 Jan 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Mar 2019.
- 29 Jan 2019 Status changed from not yet recruiting to recruiting.